Sign in
Taking peopleNo phase

The EUROSCA Natural History Study

Key facts

Who runs it
Ataxia Study Group
Where
Austria, Belgium, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, and United Kingdom16 sites in 10 countriesChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
400 people, planned
Started
Jul 2005
Expected to end
Jul 2050
Type of study
Observational
Record updated
29 June 2017

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Progressive, otherwise unexplained ataxia
  • Positive genetic testing for SCA1, SCA2, SCA3, and SCA6
  • Written informed consent by the patient or his legal agent

Who cannot take part

  • None

This trial has no sites in United States.

It has sites in 10 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The key goals of EUROSCA-NHS is to determine and compare the rate of disease progression in SCA1, SCA2, SCA3 and SCA6 including determination of the order and occurrence of non-ataxia symptoms, assessment of activities of daily living (ADL) and quality of life (QoL), and identification of predictors of disease progression and survival.

The group in the trial

  • Spinocerebellar ataxia type 1,2,3 and 6

    Spinocerebellar ataxias (SCA) are autosomal dominantly inherited progressive ataxia disorders. An epidemiological study performed in the Netherlands found a prevalence of 3.0 : 100,000 (van de Warrenburg et al. 2002). The SCA´s are genetically and clinically heterogeneous disorders with SCA1, SCA2, SCA3 and SCA6 being the most frequent genotypes worldwide. While SCA1, SCA2 and SCA3 have a complex phenotype, SCA6 patients usually present with pure cerebellar ataxia (Schols et al. 2004). Although precise knowledge of the rate of disease progression is a prerequisite for the biometrical design of future therapeutical trials, prospective studies of the natural history of SCA´s have not been performed. Similarly, the occurrence and evolution of accompanying non-ataxia symptoms have not been studied prospectively.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
29 June 2017